Carrolee Barlow, MD, Ph.D, was appointed to the Board of Directors in June 2018. Dr. Barlow is a renowned expert in neuroscience, neurodegeneration, rare diseases and clinical development of new therapies, and recently served as the Chief Medical Officer of ESCAPE Bio from 2019 to 2022. Dr. Barlow’s previous work spanned clinical care, laboratory and clinical research, academia, and industry. She is the former CEO and former board member of the Parkinson’s Institute and Clinical Center, an independent nonprofit organization, and oversaw research, clinical trials/care, and forged partnerships with biotech and pharmaceutical companies. Before joining the Parkinson’s Institute, Dr. Barlow was acting Chief Medical Officer at Amicus Therapeutics and also was a co-founder, Chief Scientific Officer, and Chief Medical Officer of BrainCells, Inc. Prior to BrainCells, she served as the Director of Molecular Neuroscience and Worldwide Therapeutic Area Head for Stroke and Neurodegeneration at Merck Research Laboratories, responsible for neuroscience biology, global exploratory, licensing and development efforts. She serves as an advisory board member and is on the Board of Directors of several biotechnology companies and disease foundations advancing therapies for rare diseases and disorders of the central nervous system. Dr. Barlow has held a faculty position at the Laboratory of Genetics at the Salk Institute for Biological Studies in La Jolla, California. Dr. Barlow received her Bachelor of Arts in English from the University of Utah and Doctor of Medicine from the University of Utah School of Medicine. In addition, she received her Doctor of Philosophy in molecular and development biology from the Karolinska Medical Nobel Institute in Stockholm, Sweden. She is an author of approximately 100 peer-reviewed research papers, and book chapters, and is an inventor on numerous patents.

Taylor Raiford has served as our Senior Vice President of Sales since May 2021. From 2012 to 2014, he served as our National Sales Director and has been responsible for building and leading the Sales Force since the inception of the Commercial Organization. In addition to the Sales Force, his responsibilities include Sales Operations and Sales Training. Prior to joining Supernus, Mr. Raiford held various positions at Shire Pharmaceuticals from 1995 to 2011, including Director-level positions in Sales, Sales Training/Leadership Development, and Marketing. Mr. Raiford earned his B.A. in Communications, Public Relations from North Carolina State University.

Frank Mottola was promoted to Senior Vice President of Quality, GMP Operations and Information Technology in 2020. Previously, he served as Vice President of Quality, GMP Operations and Information Technology beginning in 2017. From 2014-2017, he served as Vice President of Quality and GMP Operations. Initially he joined Supernus as Director of Quality in 2005, responsible for initiating Quality Systems at the company’s inception. Prior to that time, Mr. Mottola was the Director of Quality at Able Laboratories and previously held positions at Ortho Clinical Diagnostics (Johnson & Johnson). He has 24 years of experience in the pharmaceutical industry and holds a Bachelor’s degree in Biology and Business Administration while attending Rutgers University and Walden University.